1 enrolling by invitation. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow PAH: new trials by email Literature Review of PAH trials Research Report on PAH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Ralinepag - PAH, Pulmonary Hypertension | Phase 3 | Enrolling by invitation | United Therapeutics | 1000 | 2019-09-23 | 2026-10-06 |
Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Familial Primary Pulmonary Hypertension (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Lung Diseases (1) · Pulmonary Arterial Hypertension (1) · Respiratory Tract Diseases (1) · Vascular Diseases (1)
Skin and Connective Tissue Diseases (1)
ralinepag (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Croatia (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1)